Covidien PLC (NYSE:COV) had its target price boosted by Leerink Swann to $76.00 in a report issued on Wednesday, American Banking and Market News reports.
Covidien PLC (NYSE:COV) opened at 68.42 on Wednesday. Covidien PLC has a 52 week low of $49.6543 and a 52 week high of $68.88. The stock’s 50-day moving average is $64.51 and its 200-day moving average is $60.9. The company has a market cap of $31.473 billion and a P/E ratio of 18.89.
Covidien PLC (NYSE:COV) last issued its quarterly earnings data on Friday, November 8th. The company reported $0.91 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.90 by $0.01. The company had revenue of $2.56 billion for the quarter, compared to the consensus estimate of $2.56 billion. During the same quarter in the previous year, the company posted $1.02 earnings per share. The company’s revenue for the quarter was up 2.4% on a year-over-year basis. On average, analysts predict that Covidien PLC will post $3.99 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Needham & Company reiterated a buy rating on shares of Covidien PLC in a research note to investors on Tuesday. They now have a $74.00 price target on the stock. Separately, analysts at Raymond James raised their price target on shares of Covidien PLC from $72.00 to $77.00 in a research note to investors on Tuesday. They now have a hold rating on the stock. Finally, analysts at Zacks reiterated a neutral rating on shares of Covidien PLC in a research note to investors on Monday, November 11th. They now have a $67.00 price target on the stock. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of Buy and a consensus target price of $71.40.
Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.